Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Formoterol + Fluticasone in Persistent Asthma
NCT01845025Phase 4Terminated
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol in asthma, sponsored by Novartis. Started May 2013; status: terminated.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01845025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01845025.